These findings demonstrate that this CRT binding and specificity can be extended to other cell types than neutrophils and suggest that PrCP could be a general phenomenon that may occur during different biological processes such as inflammation resolution and anti-cancer surveillance (Fig. 1). This evidence concerns the gene PRCP and cancer.